Bhaskar Das

Title: Bhaskar Das: Innovator in Fibrosis and Cancer Treatment

Introduction

Bhaskar Das is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the development of treatments for fibrosis and cancer. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving health outcomes.

Latest Patents

Bhaskar Das holds a patent for "HCK inhibitors for the treatment of fibrosis and cancer." This patent includes compounds that are thiazole and triazole derivatives. The compounds are inhibitors of hematopoietic cell kinase (HCK) and exhibit anti-fibrotic and anti-proliferative effects. They are particularly useful in treating various disorders, including renal fibrosis.

Career Highlights

Bhaskar Das is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts his research. His work has garnered attention for its potential to address critical health issues related to fibrosis and cancer. With a focus on innovative solutions, he continues to push the boundaries of medical science.

Collaborations

Some of his notable coworkers include Barbara Murphy and Chengguo Wei. Their collaborative efforts contribute to the advancement of research in the field.

Conclusion

Bhaskar Das is a dedicated inventor whose work in developing HCK inhibitors represents a significant advancement in the treatment of fibrosis and cancer. His contributions to medical research are invaluable and highlight the importance of innovation in healthcare.